LeMaitre Vascular, Inc. (LMAT)
87.64
+1.04
(+1.20%)
USD |
NASDAQ |
Feb 13, 14:06
LeMaitre Vascular Cash from Investing (Quarterly) : -27.45M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ResMed, Inc. | -50.94M |
| Abbott Laboratories | -- |
| Accuray, Inc. | -- |
| Alphatec Holdings, Inc. | -13.89M |
| Plus Therapeutics, Inc. | 1.297M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 28.76M |
| Cash from Financing (Quarterly) | -2.95M |
| Free Cash Flow | 66.23M |
| Free Cash Flow Per Share (Quarterly) | 1.086 |
| Free Cash Flow to Equity (Quarterly) | 26.74M |
| Free Cash Flow to Firm (Quarterly) | 27.48M |
| Free Cash Flow Yield | 3.25% |